ClinicalTrials.Veeva

Menu

Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People (ProMuscle)

W

Wageningen University

Status

Completed

Conditions

Sarcopenia

Treatments

Dietary Supplement: Placebo drink
Dietary Supplement: Protein drink

Study type

Interventional

Funder types

Other

Identifiers

NCT01109628
A1002-1

Details and patient eligibility

About

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.

Enrollment

65 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Frail elderly individuals
  • Able to understand and perform the study procedures

Exclusion criteria

  • Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol)
  • No recent history (within 2 years) of participating in any regular resistance exercise training program (general questionnaire)
  • Use of anti-coagulation medication (except of Acetyl Salicyl acid)
  • Renal insufficiency (eGFR <60 mL/min/1.73 m2)
  • Allergic or sensitive for milk proteins

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

65 participants in 2 patient groups, including a placebo group

Protein drink
Experimental group
Treatment:
Dietary Supplement: Protein drink
Placebo drink
Placebo Comparator group
Treatment:
Dietary Supplement: Placebo drink

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems